Article Information
History
- June 13, 2019.
Article Versions
- Version 1 (May 19, 2019 - 18:19).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Prenitha Mercy Ignatius Arokia Doss1,
- Joanie Baillargeon1,
- Asmita Pradeep Yeola1,
- John B. Williams2,
- Mickael Leclercq1,
- Charles Joly-Beauparlant1,
- Melanie Alpaugh1,
- Ana C. Anderson3,
- Arnaud Droit1,4,
- Hans Lassmann5,
- Craig S. Moore2,6 and
- Manu Rangachari1,4,7
- 1Department of Neurosciences, Centre de recherche du CHU de Québec – Université Laval, Pavillon CHUL, 2705 boul Laurier, Quebec City, QC, CANADA G1V 4G2
- 2Division of BioMedical Sciences, Faculty of Medicine, Memorial University of Newfoundland, St. John’s, NL, CANADA
- 3Evergrande Center for Immunologic Diseases and Ann Romney Center for Neurologic Diseases, Harvard Medical School and Brigham & Women’s Hospital, 60 Fenwood Rd, Boston MA USA 02115
- 4Department of Molecular Medicine, Faculty of Medicine, Laval University, 1050 ave de la Médecine, Quebec City, CANADA
- 5Division of Neuroimmunology, Center for Brain Research, Medical University of Vienna, Spitalgasse 4, Vienna AUSTRIA 1090
- 6Department of Neurology, Faculty of Medicine, Memorial University of Newfoundland, St. John’s, NL, CANADA
- ↵7Corresponding author. Contact information for corresponding author: Manu Rangachari, Ph.D., Department of Neurosciences, Centre de recherche du CHU de Québec – Université Laval, Pavillon CHUL, T2-47, 2705 boul Laurier, Québec, QC CANADA G1V 4G2, Manu.rangachari{at}crchudequebec.ulaval.ca, Tel: +1-418-525-4444 x 46461